Susan G. Komen

Forty-three years ago, a sisterly promise ignited a spark that would fuel a global crusade against breast cancer. Today that promise continues to prevail as the driving force behind Susan G. Komen’s unwavering quest for a future free from the grip of this deadly disease.  

In the pursuit of our goals, we’ve helped fuel research, unlocking the biology of breast cancer and discovering insights that propel us toward more effective risk reduction strategies, earlier detection methods and innovative treatments. This has helped reduce the breast cancer mortality rate by 44% since 1989.  

To date, we’ve invested nearly $3.6 billion in groundbreaking research, community health outreach, advocacy and programs in more than 60 countries. Over the past 30 years, 29 new breast cancer-fighting drugs were made possible in part due to Komen research funding.

We stand firm in our promise to never give up on our vision of creating a world without breast cancer.